Injection for knee osteoarthritis pain relief
Part of Bones, joints & muscles clinical trials.
This study tests a new injection called 2107 to see if it helps reduce pain and improve function in people with mild to moderate knee osteoarthritis. If you're eligible, you'll receive the injection and be monitored for several months to see how it works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 40 and 80 years old.
- You must have a doctor's diagnosis of knee osteoarthritis (wear-and-tear arthritis) with symptoms for at least 6 months.
- Your knee pain must be at a moderate level (score between 40 and 80 on a 100-point pain scale) and you must have pain when walking.
- You must have had an X-ray within the last year showing mild or moderate arthritis (grade II or III).
- You must be willing to stop taking pain medications (like ibuprofen or naproxen) for at least 3 days before the study starts and during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new knee injection called CX-011 to see if it can reduce pain and improve function in people with knee osteoarthritis. It may be a good option if you have tried other treatments without enough relief.
This study tests the safety of an experimental injection called OA-SYS for people with moderate to severe knee osteoarthritis. It may help if you have not had recent injections or certain other health problems.
This study tests a new investigational medicine injected into the knee to see if it is safe and tolerable for people with painful knee osteoarthritis. It may help reduce pain and improve knee function.
This study tests whether a single injection of hyaluronic acid (a gel-like substance that helps lubricate the joint) can safely reduce knee pain from osteoarthritis. It is for people with knee pain that has lasted at least 4 weeks and who are willing to stop other pain medications during the study.
This study tests a new cell-based injection (Allocetra) directly into the knee joint for people with moderate osteoarthritis who haven't benefited from other treatments. The goal is to reduce pain and improve knee function.
This trial tests a new injectable filler called ALLOHEAL, injected directly into the knee joint to reduce pain and improve function in people with knee osteoarthritis. The filler is designed to cushion the knee joint and may help reduce pain and stiffness.
Hear when a new Mild Knee Osteoarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.